1. 1381PDGefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study. (23rd October 2018) Authors: Yang, J C-H; Cheng, Y; Murakami, H; Yang, P-C; He, J; Nakagawa, K; Kang, J H; Kim, J-H; Wnag, X; Enatsu, S; Puri, T; Orlando, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P98S100/calgranulin-mediated inflammation induces fibroblast growth factor 23 and promotes cardiac remodeling in chronic kidney disease. (15th July 2014) Authors: Hofmann-Bowman, MA; Yan, LY; Chellan, B; Gardner, B; Puri, T Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗